ASKIM, Sweden--(BUSINESS WIRE)--Oticon Medical announced today the U.S. Food and Drug Administration (FDA) clearance of its first active transcutaneous bone conduction hearing system, the Sentio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback